PB1805: INSIGHTS FROM ORAL AZACITIDINE EARLY ACCESS PROGRAM IN FRANCE: PATIENT POPULATION WITH ACUTE MYELOID LEUKEMIA RECEIVING ORAL-AZA FOR MAINTENANCE OF COMPLETE REMISSION AFTER INDUCTION CHEMOTHERAPY
oleh: E. Raffoux, S. De Botton, L. Ades, M. Carré, T. Cluzeau, C. Saillard, M. Heiblig, F. Beckerich, L. Gastaud, A. Dupuis, U. Richez, P.-Y. Dumas
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2022-06-01 |
Deskripsi
No description available for this item.